- Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside (ATNAD)
- ChromaDex wins orphan designation for rare ataxia drug
- Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia
- NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
- Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
